Pharmacogenet Genomics. 2024 Oct 16. doi: 10.1097/FPC.0000000000000550. Online ahead of print. ABSTRACT BACKGROUND: Pharmacogenomic testing identifies gene polymorphisms impacting drug metabolism, aiding in optimizing treatment …
Pharmacogenet Genomics. 2024 Oct 29. doi: 10.1097/FPC.0000000000000549. Online ahead of print. ABSTRACT BACKGROUND: Pharmacogenomic testing can optimize drug efficacy and minimize adverse effects. CYP3A5 polymorphisms …
J Perinat Med. 2024 Oct 30. doi: 10.1515/jpm-2024-0153. Online ahead of print. ABSTRACT OBJECTIVES: Determine obstetrical and neonatal outcomes in neonates with major CHD delivered …
Diabetol Int. 2024 Feb 29;15(4):679-687. doi: 10.1007/s13340-024-00698-6. eCollection 2024 Oct. ABSTRACT Diseases in which genetic factors contribute to nearly 100% of the causation by single-gene …
Port J Public Health. 2023 Aug 29;41(2):140-150. doi: 10.1159/000531587. eCollection 2023 Sep. ABSTRACT INTRODUCTION: There is a linear association between pregestational body mass index (BMI) …
Front Public Health. 2024 Oct 10;12:1432033. doi: 10.3389/fpubh.2024.1432033. eCollection 2024. ABSTRACT AIM: To explore the risk factors for low-birth-weight infants born to pregnant women with …
Cureus. 2024 Sep 27;16(9):e70316. doi: 10.7759/cureus.70316. eCollection 2024 Sep. ABSTRACT Background Chronic hypertension (CHTN) has been associated with significant maternal and neonatal complications. The goal …
Indian J Hematol Blood Transfus. 2024 Oct;40(4):682-686. doi: 10.1007/s12288-024-01778-y. Epub 2024 Apr 20. ABSTRACT INTRODUCTION: Ensuring optimal blood transfusion practices relies on a robust expertise …
Environ Sci Technol. 2024 Oct 29;58(43):19567. doi: 10.1021/acs.est.4c08062. Epub 2024 Oct 15. NO ABSTRACT PMID:39468872 | DOI:10.1021/acs.est.4c08062
Acta Myol. 2024 Sep;43(3):89-94. doi: 10.36185/2532-1900-558. ABSTRACT OBJECTIVE: We investigated myosin heavy chain (MyHC) isoform expression at early postnatal stages of clinically and genetically confirmed …
